IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 238 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $3,241,062 | +54.7% | 530,452 | +61.8% | 0.28% | +68.5% |
| Q4 2022 | $2,095,447 | -33.3% | 327,926 | 0.0% | 0.17% | -36.8% |
| Q3 2022 | $3,142,000 | -30.9% | 327,926 | -20.4% | 0.27% | -30.9% |
| Q2 2022 | $4,549,000 | -33.7% | 412,088 | -0.0% | 0.38% | -28.4% |
| Q1 2022 | $6,864,000 | -62.1% | 412,262 | -56.6% | 0.54% | -53.5% |
| Q4 2021 | $18,133,000 | -15.4% | 949,884 | +9.2% | 1.16% | -13.1% |
| Q3 2021 | $21,443,000 | +4.5% | 869,540 | +10.3% | 1.33% | +28.0% |
| Q2 2021 | $20,518,000 | +167.9% | 788,562 | +226.0% | 1.04% | +104.9% |
| Q1 2021 | $7,658,000 | – | 241,896 | – | 0.51% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 565,890 | $26,257,000 | 9.39% |
| Consonance Capital Management LP | 1,710,803 | $79,381,000 | 7.41% |
| GREAT POINT PARTNERS LLC | 917,427 | $42,569,000 | 6.91% |
| Avoro Capital Advisors LLC | 7,500,000 | $348,000,000 | 5.99% |
| Ghost Tree Capital, LLC | 500,000 | $23,200,000 | 5.17% |
| FRAZIER MANAGEMENT LLC | 1,312,999 | $60,923,000 | 4.69% |
| Perceptive Advisors | 9,166,304 | $425,316,000 | 4.56% |
| Ally Bridge Group (NY) LLC | 360,000 | $16,704,000 | 2.86% |
| Orbimed Advisors | 6,645,100 | $308,333,000 | 2.70% |
| ACUTA CAPITAL PARTNERS, LLC | 164,800 | $7,647,000 | 2.08% |